OrbiMed Advisors »

Q32 Bio shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Q32 Bio shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $38M 2.3M 17.04

More positions owned by OrbiMed Advisors

Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Edgewise Therapeutics (EWTX)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Biogen Idec (BIIB)
Merck & Co (MRK)
Janux Therapeutics (JANX)
Enliven Therapeutics (ELVN)
Tenet Healthcare Corp Com New (THC)
BioMarin Pharmaceutical (BMRN)
Alpine Immune Sciences (ALPN)
Disc Medicine (IRON)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
Vivo Capital
Arch Venture Corp
5AM Venture Management
ADAR1 Capital Management
Platinum Investment Mangement
Vanguard Group
Exome Asset Management
BlackRock
Ensign Peak Advisors
BML Capital Management
Ikarian Capital
Geode Capital Management

View all funds holding Q32 Bio